Company Profile
Suzhou Womei Biology Co., Ltd. (Womei Biology) is a one-stop solution service providers for biopharmaceuticals in China,with products including personalized media, bioreactors, immune adjuvants, biochemical reagents,etc. Womei Biology is a core supplier of upstream and downstream bioprocesses, and also provides formulation production, process optimization, process validation, technical support and ancillary services for the biopharmaceutical industry. We also provide formulation production, process optimization, process validation, technical support and supporting services for the biopharmaceutical industry. We are the leading upstream high-tech supplier of biomedicine in China,and ranked among the top in the whole biopharmaceutical upstream field.
The founding team of Womei Biology comes from the outstanding graduates of the State Key Laboratory of Bioreactor of East China University of Science and Technology (State Heavy Laboratory), and inherits more than thirty years of technology accumulation and application accumulation of the State Heavy Laboratory in the field of animal cell culture process engineering and bioreactor engineering. On the basis of the talents of this team, the company has also attracted high-level talents from Shanghai Jiao Tong University, Fudan University, Sichuan Agricultural University, Bosch of Germany and other universities and foreign enterprises. At present, the company employs more than 200 people, R & D and production level with international standards. The annual R&D investment is tens of millions of dollars.
In 2020, in order to promote the comprehensive upgrade of process development, quality system, management system and production capacity, Womei Biology initiated the construction of new plants for culture media, bioreactors and biochemical reagents in Zhangjiagang City, Suzhou, China and Qidong City, Nantong, China (WorldTex Biology), with a total area of 32,000 square meters. After the completion of the construction, it is able to realize GMP standards, the construction of low-temperature needle milling powder process capacity of more than 100,000 liters in a single batch, with a total production capacity of more than 50 million liters. It has built a leading industrial bioreactor manufacturing base in China, which can realize the production requirements of 3,000-20,000 liter bioreactors.
Relying on a strong R&D team, Womei Biology has initially completed the layout of upstream and downstream process solutions for biopharmaceuticals. In the future, it strives to build Womei Biology into a leading integrated service provider offering complete solutions in the field of biopharmaceuticals in China. We will provide more high-quality technical services for our antibody, vaccine and cell therapy enterprises; and support our innovative biopharmaceutical products, such as antibody, vaccine and cell therapy, to go out of China.
Development Path
Suzhou Womei Biology Co.,Ltd ( acronyms:Womei Biology )
Organizational Framework
Suzhou Womei Biology Co.,Ltd ( acronyms:Womei Biology )
Honor and qualification
Suzhou Womei Biology Co.,Ltd ( acronyms:Womei Biology )
You can leave a comment here about what you want to say to us, and we'll take a closer look.
Enter your message here